肌萎缩相关蛋白DAG1抗体
AGRNR; Alpha-DG; Beta-DG; Beta-dystroglycan; beta Dystroglycan; DAG; Dag1; DAG1_HUMAN; Dystroglycan 1 (dystrophin-associated glycoprotein 1); Dystroglycan; Dystrophin-associated glycoprotein 1; 156DAG
E3连接酶抑制素受体2抗体
FLJ16050; FLJ37306; HECD2_HUMAN; HECT domain containing 2; HECT domain containing protein 2; HECT domain-containing protein 2; Hectd2; OTTHUMP00000020086; OTTHUMP00000038605; Probable E3 ubiquitin pro
黑色素瘤相关突变抗原1样蛋白1抗体
9430086K21Rik; FLJ33516; Melanoma associated antigen (mutated) 1 like 1; MGC129994; MUM1-like protein 1; Mum1l1; MUML1_HUMAN; Mutated melanoma-associated antigen 1-like protein 1; OTTHUMP00000
磷酸化D酪氨酸激酶衰减蛋白2抗体
DOK2 (Phospho-Tyr351); DOK2 (Phospho Tyr351); DOK2 (Phospho Y351); Docking protein 2 56kDa; Docking protein 2 antibody DOK 2; DOK R; Downstream of tyrosine kinase 2; p56(dok 2); p56dok 2; p56DOK; p56d
磷酸化磷酯酶Cβ3抗体
Phospholipase C beta 3; Phospholipase C beta 3 (phosphatidylinositol specific); PLC beta 3; PLCB3 antibody 1 phosphatidylinositol 4 5 bisphosphate phosphodiesterase beta 3; Phosphoinositide phospholip
KDELR2蛋白抗体
Lys Asp Glu Leu) endoplasmic reticulum protein retention receptor 2; ELP 1; ELP-1; ELP1; ER lumen protein retaining receptor 2; ERD 2 like protein; ERD2 like protein 1; ERD2-like protein 1; ER
Anti-LMNA 单克隆抗体
Anti-LMNA Monoclonal Antibody 应用 WB IF 稀释比例 WB 1:1000. ICC 1:200.交叉反应 Human